Transforming Medical Radioisotope Production: The Nusano Platform

Advances in cancer diagnostics and treatments are being held back because of a shortage of the active pharmaceutical ingredients (API), medical radioisotopes. Nusano is transforming how radioisotopes are made to serve patients, empower researchers and support drugmakers. In this video, Nusano's CEO, Chris Lowe, and Co-Founder, Howard Lewin, provide an overview of the Nusano production platform. The first-of-its-kind technology allows for the simultaneous production of multiple products and provides the flexibility to create more than 30 rare and undersupplied isotopes. Visit: https://nusano.com/